← Back to Search

Continuous Glucose Monitoring System

Dexcom CGM System for Diabetes

N/A
Waitlist Available
Led By Sarit Polsky,, MD, MPH
Research Sponsored by DexCom, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days
Awards & highlights

Summary

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dexcom Continuous Glucose Monitoring (CGM) System Performance
Secondary outcome measures
System Related Adverse Device Effects

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dexcom CGM SystemExperimental Treatment1 Intervention
Dexcom CGM System

Find a Location

Who is running the clinical trial?

DexCom, Inc.Lead Sponsor
142 Previous Clinical Trials
35,233 Total Patients Enrolled
16 Trials studying Diabetes
8,672 Patients Enrolled for Diabetes
Sarit Polsky,, MD, MPHPrincipal InvestigatorBarbara Davis Center
Kristin Castorino, DOPrincipal InvestigatorSansum Diabetes Research Institute
6 Previous Clinical Trials
293 Total Patients Enrolled
~24 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top